Lower Serum n-3 Fatty Acid Level in Older Adults with Sarcopenia. Nutrients. 2020 [참여저자]
- 한울 전
- 3월 22일
- 2분 분량
Il-Young Jang,1,† Hee-Won Jung,1,† Jin Hoon Park,2 Jeoung Hee Kim,2 Seungjoo Lee,2 Eunju Lee,1 Jin Young Lee,3 So Jeong Park,3 Da Ae Kim,3 Su Jung Kim,4 Hyun Ju Yoo,4,* and Beom-Jun Kim5,*
Abstract
The n-3 fatty acid (FA) has evoked considerable interest as a modifiable factor for maintenance of muscle health owing to its anti-inflammatory properties. To clarify this possibility, we investigated circulating n-3 FA level, a reliable biomarker of FA status in the body, in relation to sarcopenia in a cohort of Asian older adults. Blood samples were collected from 125 participants who underwent comprehensive assessment of muscle mass and function. Serum FA level was measured by gas chromatography/mass spectrometry. Sarcopenia was diagnosed using the cut-off points specified for the Asian population. After adjusting for sex, age, and body mass index, subjects with sarcopenia and those with low muscle strength had 36.5% and 32.4% lower serum n-3 levels (P = 0.040 and 0.030), respectively, than controls. The odds ratios per standard deviation increment in serum n-3 level for sarcopenia and low muscle strength were 0.29 and 0.40 (P = 0.015 and 0.028), respectively. A higher serum n-3 level was significantly associated with greater muscle strength (P = 0.038). These findings suggest a possible protective effect of n-3 FA on human muscle homeostasis. Further well-designed large-scale longitudinal studies are necessary to understand the definite role of circulating n-3 FA level in sarcopenia risk assessment.
Keywords: n-3 fatty acid, sarcopenia, anti-inflammation, aging, biomarker
Figure 1
Differences in serum levels of n-3 (A) and n-6 (B) fatty acids according to the status of sarcopenia and related parameters after adjusting for sex, age, and BMI. * indicates a statistically significant difference from control. The estimated mean values with 95% confidence intervals were generated and compared using analysis of covariance. BMI, body mass index.

![Upregulation of AQP4 Improves Blood-Brain Barrier Integrity and Perihematomal Edema Following Intracerebral Hemorrhage. Neurotherapeutics. 2021 [교신저자]](https://static.wixstatic.com/media/363c9a_db43cce10804475f83191f1c8c9df768~mv2.png/v1/fill/w_668,h_403,al_c,q_85,enc_avif,quality_auto/363c9a_db43cce10804475f83191f1c8c9df768~mv2.png)
![Recent Updates on Controversies in Decompressive Craniectomy and Cranioplasty: Physiological Effect, Indication, Complication, and Management. Korean J Neurotrauma. 2023 [교신저자]](https://static.wixstatic.com/media/363c9a_38884826af3e40cdb193e5810ee325bb~mv2.png/v1/fill/w_270,h_264,al_c,q_85,enc_avif,quality_auto/363c9a_38884826af3e40cdb193e5810ee325bb~mv2.png)

댓글